See more : Sun Yad Construction Co.,Ltd (1316.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Dalrada Financial Corporation (DFCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dalrada Financial Corporation, a leading company in the Consulting Services industry within the Industrials sector.
You may be interested
- PGS ASA (PGS.OL) Income Statement Analysis – Financial Results
- Transgene SA (TRGNF) Income Statement Analysis – Financial Results
- Yotai Refractories Co., Ltd. (5357.T) Income Statement Analysis – Financial Results
- DWF Group plc (DWF.L) Income Statement Analysis – Financial Results
- KPX Holdings Co.,Ltd. (092230.KS) Income Statement Analysis – Financial Results
Dalrada Financial Corporation (DFCO)
About Dalrada Financial Corporation
Dalrada Financial Corporation and its subsidiaries provide clean energy, healthcare, technology, and precision engineering solutions. It operates through Engineering, Health, Information Technology, Education, and Corporate. The company engages in the manufacture and distribution of medical disposables, hospital equipment and furniture, medical devices, and laboratory and dental products, as well as sanitizing, disinfectant, and PPE products and services; and provision of mechanical contract services. It also provides advanced solutions for the harvesting and recycling of energy to maximize the capture and reuse of thermal energy for integrated heating and cooling applications, such as industrial, commercial, and residential sectors. In addition, the company offers software and technology solutions that specializes in test engineering, accessibility engineering, product engineering and application modernization; cleaning solutions using electrostatic machines to spray and deodorize residential spaces, healthcare facilities, hospitality, transportation, manufacturing, automotive, schools/education systems, and other facilities. Further, it provides trained nursing and medical assistants for hospitals and home health facilities; and regenerative therapy as a potential solution for the prevention, detection, and treatment of cellular breakdown associated with aging and various other conditions, as well as explores various products and services within the immunization and personal protective equipment industry. The company has operations in Malaysia, India, the United Kingdom, and the United States. Dalrada Financial Corporation was founded in 1982 and is based in Escondido, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.74M | 19.27M | 3.41M | 1.18M | 72.16K | 0.00 | 70.38M | 19.48M | 13.53M | 4.19M | 25.25M | 3.45M | 2.55M | 17.30M | 34.40M | 30.60M | 11.60M | 14.40M | 11.10M | 10.20M | 10.30M | 7.20M | 10.50M | 9.50M | 9.30M | 4.20M | 1.80M |
| Cost of Revenue | 20.68M | 8.76M | 2.47M | 625.92K | 75.00K | 0.00 | 63.93M | 16.53M | 10.30M | 2.30M | 23.20M | 2.74M | 1.87M | 13.30M | 21.80M | 15.50M | 9.60M | 11.60M | 9.80M | 4.70M | 4.90M | 5.50M | 8.10M | 8.10M | 7.20M | 2.80M | 1.40M |
| Gross Profit | 9.06M | 10.51M | 934.72K | 552.24K | -2.84K | 0.00 | 6.45M | 2.95M | 3.22M | 1.89M | 2.05M | 710.00K | 679.00K | 4.00M | 12.60M | 15.10M | 2.00M | 2.80M | 1.30M | 5.50M | 5.40M | 1.70M | 2.40M | 1.40M | 2.10M | 1.40M | 400.00K |
| Gross Profit Ratio | 30.46% | 54.53% | 27.44% | 46.87% | -3.94% | 0.00% | 9.17% | 15.13% | 23.84% | 45.13% | 8.13% | 20.57% | 26.66% | 23.12% | 36.63% | 49.35% | 17.24% | 19.44% | 11.71% | 53.92% | 52.43% | 23.61% | 22.86% | 14.74% | 22.58% | 33.33% | 22.22% |
| Research & Development | 120.00K | 657.00K | 520.51K | 471.96K | 50.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.00K | 2.05M | 2.20M | 2.50M | 4.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 29.47M | 20.07M | 8.98M | 2.77M | 721.85K | 91.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 29.47M | 20.07M | 8.98M | 2.77M | 721.85K | 91.98K | 11.19M | 5.58M | 4.20M | 7.59M | 12.44M | 8.72M | 7.78M | 13.70M | 10.30M | 9.40M | 3.20M | 4.40M | 4.40M | 4.40M | 4.40M | 6.00M | 5.20M | 3.50M | 3.80M | 2.90M | 1.70M |
| Other Expenses | 433.56K | 308.53K | 114.40K | 1.23M | 2.26M | -183.97K | 0.00 | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 3.33M | 4.80M | 700.00K | 900.00K | 400.00K | 800.00K | 700.00K | 300.00K | 200.00K | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | 200.00K |
| Operating Expenses | 30.02M | 20.72M | 9.50M | 3.24M | 771.90K | 91.98K | 11.19M | 6.93M | 4.20M | 7.59M | 12.44M | 8.97M | 13.16M | 20.70M | 13.50M | 14.50M | 3.60M | 5.20M | 5.10M | 4.70M | 4.60M | 6.30M | 5.30M | 3.70M | 4.00M | 3.10M | 1.90M |
| Cost & Expenses | 50.70M | 29.48M | 11.98M | 3.87M | 846.89K | 91.98K | 75.12M | 23.46M | 14.50M | 9.89M | 35.64M | 11.71M | 15.03M | 34.00M | 35.30M | 30.00M | 13.20M | 16.80M | 14.90M | 9.40M | 9.50M | 11.80M | 13.40M | 11.80M | 11.20M | 5.90M | 3.30M |
| Interest Income | 79.76K | 4.45K | 6.28K | 8.77K | 853.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.55M | 1.30M | 670.27K | 1.04M | 853.18K | 945.24K | 2.70M | 1.71M | 1.93M | 0.00 | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K | 0.00 | 0.00 | 400.00K | 400.00K | 300.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 707.57K | 252.94K | 112.50K | 46.60K | 774.74K | 91.98K | 1.34M | 510.00K | 1.18M | 1.07M | 972.00K | 806.00K | 3.33M | 4.80M | 700.00K | 900.00K | -400.00K | -800.00K | -700.00K | -300.00K | -200.00K | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | 200.00K |
| EBITDA | -17.37M | -9.88M | 783.99K | -1.39M | 1.22M | -91.98K | -3.40M | -3.47M | 203.00K | -4.62M | -9.42M | -7.45M | -9.16M | -11.90M | -200.00K | 1.40M | -1.20M | -1.60M | -3.10M | 1.10M | 1.00M | -4.30M | -2.80M | -2.10M | -1.70M | -1.50M | -1.30M |
| EBITDA Ratio | -58.40% | -49.73% | -243.88% | -223.53% | -1,073.71% | 0.00% | -19.69% | -18.15% | 1.45% | -166.85% | -37.29% | -168.77% | -364.90% | -32.37% | 25.58% | 4.58% | 7.76% | -11.11% | -27.93% | 10.78% | 16.50% | -55.56% | -49.52% | -41.05% | -35.48% | -54.76% | -100.00% |
| Operating Income | -20.96M | -10.22M | -8.57M | -2.69M | -774.74K | -91.98K | -4.74M | -3.98M | -972.00K | -5.70M | -10.39M | -8.26M | -12.48M | -16.70M | -900.00K | 600.00K | -1.60M | -2.40M | -3.80M | 800.00K | 800.00K | -4.60M | -2.90M | -2.30M | -1.90M | -1.70M | -1.50M |
| Operating Income Ratio | -70.48% | -53.03% | -251.57% | -228.23% | -1,073.71% | 0.00% | -6.73% | -20.44% | -7.19% | -135.92% | -41.14% | -239.28% | -490.15% | -96.53% | -2.62% | 1.96% | -13.79% | -16.67% | -34.23% | 7.84% | 7.77% | -63.89% | -27.62% | -24.21% | -20.43% | -40.48% | -83.33% |
| Total Other Income/Expenses | 332.24K | -1.00M | 8.57M | 211.54K | 1.14M | -945.24K | 7.77M | -121.00K | -1.92M | -1.16M | -3.30M | -1.63M | -1.71M | -8.10M | -9.00M | -13.00K | -2.10M | 0.00 | 0.00 | 0.00 | -700.00K | -300.00K | 2.10M | 1.80M | 1.60M | 800.00K | 500.00K |
| Income Before Tax | -20.63M | -11.44M | 1.22K | -2.48M | 365.85K | -1.04M | 3.03M | -4.28M | -2.90M | -6.86M | -13.69M | -9.89M | -12.35M | -24.80M | -9.90M | 600.00K | -3.70M | 0.00 | 0.00 | 800.00K | 100.00K | -4.90M | -800.00K | -500.00K | -300.00K | -900.00K | -1.00M |
| Income Before Tax Ratio | -69.36% | -59.37% | 0.04% | -210.29% | 507.03% | 0.00% | 4.30% | -21.96% | -21.40% | -163.60% | -54.20% | -286.44% | -484.69% | -143.35% | -28.78% | 1.96% | -31.90% | 0.00% | 0.00% | 7.84% | 0.97% | -68.06% | -7.62% | -5.26% | -3.23% | -21.43% | -55.56% |
| Income Tax Expense | 0.00 | 132.51K | 694.46K | 1.03M | -1.99M | -91.98K | 40.00K | 238.00K | -1.07M | 1.16M | 0.00 | 1.63M | 1.71M | 300.00K | 9.30M | -200.00K | 2.80M | 1.30M | 1.60M | 100.00K | 1.10M | 800.00K | 100.00K | -1.40M | -1.50M | -900.00K | -500.00K |
| Net Income | -20.29M | -11.57M | -693.24K | -3.51M | 2.36M | -1.04M | 2.62M | -4.22M | 102.00K | -6.86M | -13.69M | -9.89M | -14.20M | -25.10M | -10.20M | 800.00K | -3.60M | -2.10M | -4.00M | 700.00K | 100.00K | -5.40M | -900.00K | -900.00K | -400.00K | -800.00K | -1.00M |
| Net Income Ratio | -68.24% | -60.06% | -20.35% | -297.76% | 3,270.20% | 0.00% | 3.73% | -21.66% | 0.75% | -163.60% | -54.20% | -286.44% | -557.44% | -145.09% | -29.65% | 2.61% | -31.03% | -14.58% | -36.04% | 6.86% | 0.97% | -75.00% | -8.57% | -9.47% | -4.30% | -19.05% | -55.56% |
| EPS | -0.24 | -0.16 | -0.01 | -0.06 | 0.05 | -0.02 | 0.63 | -1.28 | 0.06 | -14.23 | -224.38 | -300.80 | -545.05 | -6.48K | -3.60K | 280.00 | -1.26K | -735.04 | -1.40K | 245.01 | 35.00 | -1.89K | -315.02 | -315.02 | -140.01 | -280.01 | -350.02 |
| EPS Diluted | -0.24 | -0.16 | -0.01 | -0.06 | 0.02 | -0.02 | 0.35 | -1.28 | 0.06 | -14.23 | -224.38 | -300.80 | -545.05 | -6.48K | -3.60K | 240.00 | -1.26K | -735.04 | -1.40K | 245.01 | 35.00 | -1.89K | -315.02 | -315.02 | -140.01 | -280.01 | -350.02 |
| Weighted Avg Shares Out | 83.76M | 72.22M | 70.32M | 56.80M | 47.43M | 47.28M | 4.11M | 3.29M | 1.66M | 481.58K | 61.01K | 32.87K | 26.05K | 3.87K | 2.83K | 2.50K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K |
| Weighted Avg Shares Out (Dil) | 83.76M | 72.22M | 128.95M | 56.80M | 102.58M | 47.28M | 19.35M | 3.29M | 1.66M | 481.58K | 61.01K | 32.87K | 26.05K | 3.87K | 2.83K | 2.92K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K |
Dalrada Financial Corporation establishes Deposition Technology Inc. U.S. Presence with new Portland Facility
New site will accelerate the production and sales of deposition technology products to support the expanding North American and global markets. SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) ("Dalrada," "the Company"), a global...
Dalrada Financial Corporation Selects CM3 Advisory as Independent Registered Public Accounting Firm
SAN DIEGO, CA / ACCESSWIRE / October 24, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) ("Dalrada," "the Company"), announced today that it has engaged the PCAOB auditing firm, CM3 Advisory ("CM3"), as its independent registered public accounting firm. With years of...
Dalrada Financial Corporation Provides Update on Selection of New PCAOB Auditing Firm
SAN DIEGO, CA / ACCESSWIRE / October 17, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) ("Dalrada," "the Company"), announced today that the company is currently active in the process of interviewing several PCAOB auditing firms to replace Assurance Dimensions. The company...
Dalrada Financial Corporation CEO Appoints Pauline Gourdie as Chief of Staff
Accomplished business leader with extensive experience at Fortune 500 Companies will drive Dalrada's global success by enhancing operational efficiency. SAN DIEGO, CA / ACCESSWIRE / October 8, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) ("Dalrada," "the Company"), announced today that Pauline...
Dalrada Financial Corporation Signs Contract with France-Based Onet Group for Heat Pump Installation in Light Industrial Facility
Initial agreement is expected to accelerate additional opportunities across multiple French and Spanish facilities, expanding Dalrada's European footprint. SAN DIEGO, CA / ACCESSWIRE / September 12, 2024 / Dalrada Financial Corporation (OTCQB:DFCO), ("Dalrada," "the Company"), announced today that it had...
Dalrada Financial Corporation Finalizes Exclusive Master Distribution Agreement with Applied Technologies of New York
New agreement secures exclusive distribution of Dalrada's heat pump technology, targeting sales of 600 heat pumps while expanding the company's product and service footprint. SAN DIEGO, CA / ACCESSWIRE / August 20, 2024 / Dalrada Financial Corporation (OTCQB:DFCO), ("Dalrada," "the...
CEO of Dalrada Financial Corporation Subsidiary, Genefic, Inc. Discusses Revenue Drivers and Growth in New Interview
Dan Riley provides updates and insights about the subsidiary's success and significant revenue growth SAN DIEGO, CA / ACCESSWIRE / July 24, 2024 / Genefic, Inc. , a wholly-owned subsidiary of Dalrada Financial Corporation (OTCQB:DFCO),("Dalrada," "the Company"), announced the release...
Dalrada's Brian Bonar Wins San Diego Business Journal's CEO of the Year
CEO and Chairman wins the prestigious 2024 award for the company's respective business category SAN DIEGO, CA / ACCESSWIRE / July 17, 2024 / Dalrada Financial Corporation (OTCQB:DFCO), "Dalrada," "the Company"), announced today that Chairman and CEO Brian Bonar has...
Dalrada Financial Corporation CEO Discusses Increased Corporate Momentum and Shares Company Updates in New Interview
Brian Bonar provides executive insight and shares exciting company news with SmallCapVoice SAN DIEGO, CA / ACCESSWIRE / July 15, 2024 / Dalrada Financial Corporation (OTCQB:DFCO), ("Dalrada," "the Company"), announces the availability of a new insightful interview with Company CEO...
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy. SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada,” “the Company”), announced today that its wholly-owned healthcare subsidiary, Genefic, Inc. (“Genefic”), had...
Source: https://incomestatements.info
Category: Stock Reports